Literature DB >> 15937280

Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer.

Limin Wang1, Wilfredo Colón.   

Abstract

Serum Amyloid A (SAA) is an acute phase reactant protein that is predominantly found bound to high-density lipoprotein in plasma. Upon inflammation, the plasma concentration of SAA can increase dramatically, occasionally leading to the development of amyloid A (AA) amyloidosis, which involves the deposition of SAA amyloid fibrils in major organs. We previously found that the murine isoform SAA2.2 exists in aqueous solution as a hexamer containing a central channel. Here we show using various biophysical and biochemical techniques that the SAA2.2 hexamer can be totally dissociated into monomer by approximately 2 M urea, with the concerted loss of its alpha-helical structure. However, limited trypsin proteolysis experiments in urea showed a conserved digestion profile, suggesting the preservation of major backbone topological features in the urea-denatured state of SAA2.2. The marginal stability of hexameric SAA2.2 and the presence of residual structure in the denatured monomeric protein suggest that both forms may interconvert in vivo to exert different functions to meet the various needs during normal physiological conditions and in response to inflammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937280      PMCID: PMC2253367          DOI: 10.1110/ps.051387005

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

Review 1.  Natively unfolded proteins: a point where biology waits for physics.

Authors:  Vladimir N Uversky
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

Review 2.  Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm.

Authors:  P E Wright; H J Dyson
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

3.  Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease.

Authors:  Joris R Delanghe; Michel R Langlois; Dirk De Bacquer; Rudolf Mak; Paul Capel; Lieve Van Renterghem; Guy De Backer
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

Review 4.  Markers of inflammation and coronary artery disease.

Authors:  Salam M Saadeddin; Moh'd A Habbab; Gordon A Ferns
Journal:  Med Sci Monit       Date:  2002-01

5.  Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.

Authors:  J D Gillmore; L B Lovat; M R Persey; M B Pepys; P N Hawkins
Journal:  Lancet       Date:  2001-07-07       Impact factor: 79.321

6.  From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature.

Authors:  Limin Wang; Hilal A Lashuel; Wilfredo Colón
Journal:  Amyloid       Date:  2005-09       Impact factor: 7.141

7.  Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel.

Authors:  Limin Wang; Hilal A Lashuel; Thomas Walz; Wilfredo Colon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

Review 8.  Inflammation and atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Attilio Maseri
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

9.  The interaction between apolipoprotein serum amyloid A and high-density lipoprotein.

Authors:  Limin Wang; Wilfredo Colón
Journal:  Biochem Biophys Res Commun       Date:  2004-04-23       Impact factor: 3.575

10.  Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein.

Authors:  K P McAdam; J D Sipe
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  5 in total

1.  Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer.

Authors:  Yun Wang; Saipraveen Srinivasan; Zhuqiu Ye; J Javier Aguilera; Maria M Lopez; Wilfredo Colón
Journal:  Biochem Biophys Res Commun       Date:  2011-03-31       Impact factor: 3.575

2.  Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.

Authors:  Saipraveen Srinivasan; Sanket Patke; Yun Wang; Zhuqiu Ye; Jeffrey Litt; Sunit K Srivastava; Maria M Lopez; Dmitry Kurouski; Igor K Lednev; Ravi S Kane; Wilfredo Colón
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

3.  Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.

Authors:  J Javier Aguilera; Fuming Zhang; Julie M Beaudet; Robert J Linhardt; Wilfredo Colón
Journal:  Biochimie       Date:  2014-05-28       Impact factor: 4.079

4.  Colocalization of serum amyloid a with microtubules in human coronary artery endothelial cells.

Authors:  Katja Lakota; Nataša Resnik; Katjuša Mrak-Poljšak; Snežna Sodin-Šemrl; Peter Veranič
Journal:  J Biomed Biotechnol       Date:  2011-10-27

5.  Characterization of the oligomerization and aggregation of human Serum Amyloid A.

Authors:  Sanket Patke; Saipraveen Srinivasan; Ronak Maheshwari; Sunit K Srivastava; J Javier Aguilera; Wilfredo Colón; Ravi S Kane
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.